PDS Biotechnology
PDSB
PDSB
55 hedge funds and large institutions have $166M invested in PDS Biotechnology in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
+1
Holders Change %
+1.85%
% of All Funds
1.37%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
6
Increased
23
Reduced
14
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Franklin Resources
San Mateo,
California
|
$34.3M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$4.06M |
| 3 |
SFM
3
Sphera Funds Management
Tel Aviv,
Israel
|
$3.58M |
| 4 |
4
Renaissance Technologies
New York
|
$1.85M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$8.5M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| $7K | +$7K | +33 | New |
|
52
Barclays
London,
United Kingdom
| $5K | +$1.52K | +7 | +44% |
|
|
MAM
53
Meeder Asset Management
Dublin,
Ohio
| $3K | – | – | – |
|
54
Citigroup
New York
| $1K | -$1.33K | -4 | -57% |
|
|
WPC
55
White Pine Capital
Bloomington,
Minnesota
| $125 | +$125 | +581 | New |
|
|
OM
56
Opaleye Management
Boston,
Massachusetts
| – | -$1.33M | -6,500 | Closed |
|
57
Goldman Sachs
New York
| – | -$374K | -1,824 | Closed |
|
58
SG Americas Securities
New York
| – | -$236K | -1,149 | Closed |
|
|
TC
59
TFS Capital
West Chester,
Pennsylvania
| – | -$206K | -1,004 | Closed |
|
|
PAM
60
Panagora Asset Management
Boston,
Massachusetts
| – | -$8K | -41 | Closed |
|